Heartflow (NASDAQ:HTFL) Hits New 52-Week High – Time to Buy?

Heartflow, Inc. (NASDAQ:HTFL) reached a new 52-week high during mid-day trading on Wednesday. The company traded as high as $60.66 and last traded at $60.0040, with a volume of 852,071 shares changing hands. The stock had previously closed at $55.80.

Analyst Ratings Changes

A number of brokerages have recently commented on HTFL. Morgan Stanley boosted their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. raised their target price on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Heartflow in a research note on Wednesday, November 4th. Wall Street Zen lowered shares of Heartflow from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $48.62.

Heartflow Stock Performance

The company has a market cap of $5.18 billion, a price-to-earnings ratio of -32.67 and a beta of 2.50. The firm has a fifty day moving average price of $51.56 and a 200 day moving average price of $34.87.

Heartflow (NASDAQ:HTFL) last released its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. Heartflow’s revenue was up 47.7% compared to the same quarter last year. On average, analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Insider Buying and Selling at Heartflow

In other news, insider Campbell Rogers sold 23,933 shares of the business’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33. Following the transaction, the insider directly owned 73,453 shares in the company, valued at $4,040,649.53. The trade was a 24.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 3,587 shares of the company’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $53.15, for a total transaction of $190,649.05. Following the completion of the sale, the chief financial officer directly owned 149,587 shares in the company, valued at approximately $7,950,549.05. The trade was a 2.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 347,963 shares of company stock worth $17,210,559 over the last quarter. 7.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Heartflow

A number of hedge funds and other institutional investors have recently bought and sold shares of HTFL. Teachers Retirement System of The State of Kentucky acquired a new position in Heartflow during the third quarter worth approximately $1,684,000. Allworth Financial LP lifted its position in shares of Heartflow by 116.4% in the third quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock valued at $57,000 after buying an additional 616 shares during the last quarter. Pier 88 Investment Partners LLC acquired a new stake in shares of Heartflow in the third quarter valued at approximately $174,000. M&G PLC bought a new position in shares of Heartflow during the 3rd quarter worth approximately $15,978,000. Finally, Pictet Asset Management Holding SA bought a new position in shares of Heartflow during the 3rd quarter worth approximately $551,000.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.